Quantcast

Latest epilepsy Stories

2014-06-25 10:19:51

University of California - Irvine Noninvasive diagnostic technique could greatly enhance use of preventive therapies A newly discovered biomarker – visible in brain scans for hours after febrile seizures – predicts which individuals will subsequently develop epilepsy, according to UC Irvine researchers. This diagnostic ability could lead to improved use of preventive therapies for the disorder. A team led by Dr. Tallie Z. Baram found that rats exhibiting this novel signal in...

2014-06-17 12:28:18

SALT LAKE CITY and TORONTO, June 17, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules expands on its pharmaceutical research and development plans. EastGate has entered into a working collaboration with Dr. Peter Carlen, leading neurologist at Toronto Western Hospital,...

2014-06-17 08:26:35

Recently FDA Approved Qudexy(TM) XR Offers a New Treatment Option for Managing Specific Seizure Types MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- Results from Upsher-Smith Laboratories, Inc.'s, Phase 3 study of USL255, Qudexy(TM) XR (topiramate) extended-release capsules, a proprietary, once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile, were published in the June issue of Epilepsia, a leading, authoritative...

2014-06-17 00:20:31

WOODCLIFF LAKE, N.J., June 16, 2014 /PRNewswire/ -- Eisai Inc. announced today that a Phase III clinical trial (study 332) of its in-house-discovered AMPA receptor antagonist perampanel has met its primary endpoint in patients with primary generalized tonic-clonic (PGTC) seizures, a severe form of seizures. http://photos.prnewswire.com/prnvar/20120413/MM87168LOGO Study 332 was a double-blind, randomized, placebo-controlled, multicenter, parallel-group trial to evaluate the efficacy and...

2014-06-13 12:23:30

Pre-Game Activities Honor Local Epilepsy Awareness Ambassador Families NEW YORK, June 13, 2014 /PRNewswire-iReach/ -- The Epilepsy Foundation of Metropolitan New York will host its 2(nd) Annual Epilepsy Awareness Day at Citi Field during a matchup between the New York Mets and the San Diego Padres at Citi Field on Father's Day, Sunday, June 15, 2014. The event will feature several exhibits and family activities designed to help raise public awareness about epilepsy and to celebrate...

2014-06-13 08:22:40

Pre-Game Activities Honor Local Epilepsy Awareness Ambassadors WOODCLIFF LAKE, N.J., June 13, 2014 /PRNewswire/ -- Eisai Inc. announced today it has become a "Keeper of the Flame" sponsor of the Epilepsy Foundation of Metropolitan New York's 2(nd) Annual Epilepsy Awareness Day which will take place during a baseball game between the New York Mets and the San Diego Padres at Citi Field on Father's Day, June 15, 2014. The event will feature several exhibits and family activities...

2014-06-10 16:27:34

For people who don't respond to medications, SEEG pinpoints and eliminates exact source of seizures in brains CHICAGO, June 10, 2014 /PRNewswire-USNewswire/ -- For the more than 2 million Americans living with epilepsy, managing seizures is the key to living a normal life. And for many, medications do just that - allowing them to drive, have jobs and raise families. But for almost one-third of epileptics, medicine is not enough. Specialists at Northwestern Medicine's Comprehensive...

2014-06-03 23:03:56

The AKC Canine Health Foundation (CHF) has taken a major step to better understand epilepsy in dogs with the launch of an Epilepsy Research Initiative. The Initiative will provide dog owners and the veterinary community with improved methods for preventing and treating epilepsy in dogs. Raleigh, NC (PRWEB) June 03, 2014 The AKC Canine Health Foundation (CHF) has taken a major step to better understand epilepsy in dogs with the launch of an Epilepsy Research Initiative. The goal of the...

2014-06-03 12:39:14

Epilepsy Organizations, Scientists, Bereaved Parents & Epilepsy Patients to Join Forces MINNEAPOLIS, June 3, 2014 /PRNewswire-USNewswire/ -- When 4-year-old Henry Lapham was diagnosed with epilepsy, his parents Gardiner and Nicholas Lapham were devastated, but certain that with the proper care and medication, everything would be fine. Nothing could be further from the truth. A mere five weeks after Henry's diagnosis, a seizure took his life. He died from a phenomenon called Sudden...

2014-06-03 08:31:20

LOS ANGELES, June 03, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) System for the treatment of neurological and neuropsychiatric disorders, today announced that Ian A. Cook, M.D., has joined NeuroSigma on June 1, 2014 as Chief Medical Officer and Senior Vice President. Dr. Cook is a physician and bioengineer who has been an innovator in medical therapeutics and...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.